Utah Attorney General Sues Lilly For Medicaid Funds Spent On Zyprexa
This article was originally published in The Pink Sheet Daily
State also has assumed cost of caring for recipients who consumed prescriptions that were “actively harmful,” AG claims.
You may also be interested in...
Senate Finance Committee ranking member requests all documents and materials relating to product liability litigation involving Lilly’s antipsychotic by April 25.
The settlement resolves suits alleging Lilly inadequately warned patients of the risks of diabetes and hyperglycemia associated with the antipsychotic.
Settlement will cover approximately 8,000 personal injury claims regarding diabetes and hyperglycemia, or about 75% of the total number of cases, Lilly says. “Lilly is prepared to continue its vigorous defense of Zyprexa in the remaining cases,” the company said.